Table of Contents Table of Contents
Previous Page  20 / 21 Next Page
Information
Show Menu
Previous Page 20 / 21 Next Page
Page Background

Page 93

conferenceseries

.com

Volume 8

Journal of Gastrointestinal & Digestive System

ISSN: 2161-069X

Gastro Congress 2018

August 20-21, 2018

August 20-21, 2018 | Rome, Italy

13

th

Euro-Global

Gastroenterology Conference

Prevelance of occult HBV in chronic hepatitis C and cryptogenic hepatitis patients

Bülent Çakal

Istanbul University, Turkey

O

ccult hepatitis B Virus (HBV) infection (OBI) is considered as the possible a phase of the HBV natural history but it

remains unclear the molecular mechanisms and clinical impact and epidemiology aspect of OBİ. We investigated the

prevalence of OBI and its clinical impact among patients with Hepatitis C virus (HCV) infection and with cryptogenic hepatitis.

This study protocol was approved by the ethics committee of İstanbul University- School of Medicine (No: 2015/1519). This

prospective cohort study included a total of 60 HBsAg-negative patients (27 patients with chronic HCV and 33 patients with

cryptogenic hepatitis) were enrolled in Department of Gastroenterology, Istanbul Faculty of Medicine. Liver tissue samples

had been obtained by percutaneous needle liver biopsy and immediately frozen and stored at -80°C. Total nucleic acids were

extracted from frozen liver biopsies using QIAamp DNA Mini Kit (Qiagen) according to the manufacturer’s instructions. OBI

was defined as HBV DNA positivity in two or more different viral genomic regions by nested polymerase chain reaction PCR

using 4 sets of primers in preS-S (S), precore-core (C), Pol, and X viral regions of the HBV genome. Plasmid HBV DNA 4.1 kb

and liver biopsy samples obtained from patients with chronic HBV infection (positive control) were used. Statistical analyses

were evaluated using Mann–Whitney U, Chi-square test and Kruskal Wallis tests. The baseline characteristics of patients are

presented in figure 1. The prevalence of OBI was 25.9% (7/26) with 27.3% (9/33), 26.7% (16/60) in patients anti-HCV (+),

cryptogenic hepatitis, and totaly respectively. There wasn’t significant differences for prevelance of OBİ between patients with

Chronic HCV infection and cryptogenic hepatitis (P=0.907). Patients with anti-HCV (+), OBİ (+) were older compared with

patients anti-HCV (+), OBİ (-), (P: 0.033). As it is expected that cryptogenic hepatitis patients had higher serum alkaline

phosphatase and gamma-glutamyltransferase level. Clinical signifance and role of OBI in patients with chronic HCV infection

is controversial. According to first results of the study, prevelance of OBİ is correlated with endemicity of Hepatitis B infection

moreover OBİ can be associated with liver injury rather than chronic HCV infection. Therefore, it appears that host factors

rather than viral factors are more responsible for OBI.

bulentcakal@yahoo.com

J Gastrointest Dig Syst 2018, Volume 8

DOI: 10.4172/2161-069X-C5-077